Company / Financials
HARVARD BIOSCIENCE INC Financials
FY2011-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableRevenue
$94.1M
FY2025 · -16.1% YoY
Net Income
-$12.4M
FY2025 · -263.3% YoY
Profit Margin
-13.2%
FY2025 · net income / revenue
ROE
-19.6%
FY2025 · return on equity
Total Assets
$80.1M
FY2025
Total Debt
$35.9M
0.57x debt/equity
Equity
$63.3M
FY2025
ROA
-15.5%
FY2025 · return on assets
Statement paths
Financial highlights
Key Data Points
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Metric history
Revenue HistoryTotal revenue from operations$94.1M-16.1% YoYNet Income HistoryProfit after all expenses and taxes-$12.4M-263.3% YoYGross Profit HistoryRevenue minus cost of goods sold$54.8M-17.1% YoYCost of Revenue HistoryDirect costs of producing goods and services sold$39.4M-14.7% YoYOperating Income HistoryProfit from core business operations before interest and taxes-$6.2M-427.9% YoYSG&A Expense HistorySelling, general, and administrative expenses$21.5M-5.6% YoYR&D Expense HistoryResearch and development spending$10.4M-11.5% YoYInterest Expense HistoryCost of borrowing and debt obligations$3.2MIncome Tax HistoryTotal income tax expense$740.0K-13.9% YoYEPS (Basic) HistoryBasic earnings per share-$0.28-250.0% YoY